Terry L Melim

Title: Innovations of Terry L Melim

Introduction

Terry L Melim is a notable inventor based in Derry, NH (US). He has made significant contributions to the field of biotechnology, particularly in the development of interleukin-13 binding proteins. With a total of five patents to his name, Melim's work has the potential to impact medical treatments significantly.

Latest Patents

One of Melim's latest patents focuses on interleukin-13 binding proteins. This invention encompasses antibodies that are chimeric, CDR grafted, and humanized. The preferred antibodies exhibit high affinity for human interleukin-13 (hIL-13) and are designed to neutralize hIL-13 activity both in vitro and in vivo. The invention includes methods for making and using these antibodies, which are useful for detecting hIL-13 and inhibiting its activity in human subjects suffering from disorders where hIL-13 activity is detrimental.

Career Highlights

Throughout his career, Terry L Melim has worked with prominent companies in the biotechnology sector, including AbbVie Inc. and Abbott Laboratories Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field.

Collaborations

Some of Melim's notable coworkers include Chengbin Wu and Richard W Dixon. Their collaborative efforts have likely enhanced the research and development of the technologies he has pioneered.

Conclusion

Terry L Melim's contributions to biotechnology, particularly through his patents on interleukin-13 binding proteins, showcase his innovative spirit and dedication to advancing medical science. His work continues to hold promise for future therapeutic applications.